ScholarIQanswers from OpenAlex & ORCID
Vera Golder
ResearcherPublications, citations & collaboration network
Vera Golder is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Vera Golder have?
ScholarIQindexed works
Vera Golder has 111 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Vera Golder have?
ScholarIQcitation count
Vera Golder has 1,829 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Vera Golder?
ScholarIQh-index
Vera Golder has an h-index of 24 in OpenAlex.
What is the i10-index of Vera Golder?
ScholarIQi10-index
Vera Golder has an i10-index of 36 in OpenAlex.
What is the ORCID of Vera Golder?
ScholarIQorcid
The ORCID for Vera Golder is on the source record.
What is the OpenAlex record for Vera Golder?
ScholarIQopenalex
The OpenAlex for Vera Golder is on the source record.
What are the most-cited papers on Vera Golder?
ScholarIQmost cited works
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study
Vera Golder, Rangi Kandane‐Rathnayake, Molla Huq, Hieu T. Nim, Worawit Louthrenoo, Shue Fen Luo, Yeong‐Jian Jan Wu, Aisha Lateef, Sargunan Sockalingam, Sandra Navarra, Leonid Zamora, Laniyati Hamijoyo, Yasuhiro Katsumata, Masayoshi Harigai, Madelynn Chan, Sean O’Neill, Fiona Goldblatt, Chak Sing Lau, Zhan Guo Li, Alberta Hoi, Mandana Nikpour, Eric F. Morand
Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study
Vera Golder, Rangi Kandane‐Rathnayake, Alberta Hoi, Molla Huq, Worawit Louthrenoo, Yuan An, Zhan Guo Li, Shue Fen Luo, Sargunan Sockalingam, Chak Sing Lau, Mo Yin Mok, Aisha Lateef, Kate Franklyn, Susan Morton, Sandra Navarra, Leonid Zamora, Yeong-Jian Jan Wu, Laniyati Hamijoyo, Madelynn Chan, Sean O’Neill, Fiona Goldblatt, Mandana Nikpour, Eric F. Morand
Ankylosing spondylitis: an update.
Vera Golder, Lionel Schachna
Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus
Shereen Oon, Molla Huq, Vera Golder, Pei Xuan Ong, Eric F. Morand, Mandana Nikpour
Discordance of patient and physician health status concerns in systemic lupus erythematosus
Vera Golder, James Jian Yun Ooi, A S Antony, Tina Ko, Susan Morton, Rangi Kandane‐Rathnayake, Eric F. Morand, Alberta Hoi